Screening methods and implementation
Saturday, June 18, 2016
Oral Communications
•
OC 14
•
10:30 AM
>
12:30 PM
•
Screening methods and implementation
•
Trakl
Oral Communications
•
OC 14-01
•
Risk of cervical cancer after a negative smear by age
See abstract
>
I.
I.M.
De Kok
•
OC 14-02
•
Cervical cancer mortality in un(der)screened women in the Netherlands
See abstract
>
S.
Steffie
Naber
•
OC 14-03
•
Effect of organized screening and opportunistic testing in cervical cancer in Finland among young women
See abstract
>
P.
Petra
Makkonen
•
OC 14-04
•
Impact of Cytology Lab Service Delivery on the Cervical Health Screening Algorithm
See abstract
>
K.
Kristi
Valentine
•
OC 14-05
•
Cumulative probability of abnormalities in organized cervical cancer screening
See abstract
>
M.
Maiju
Pankakoski
•
OC 14-06
•
Audit of screening histories and effectiveness of screening
See abstract
>
S.
Stefan
Lönnberg
•
OC 14-07
•
Nine years experience in 412.000 cases: liquid based cytology and computer assistance compared to conventional cytology
See abstract
>
H.
Hans
Ikenberg
•
OC 14-08
•
Liquid-based cytology and human papillomavirus testing in the cervical screening programme in Luxembourg
See abstract
>
A.
Ardashel
Latsuzbaia
•
OC 14-09
•
Evaluation of organised primary HPV screening of women aged 30-64 in Sweden
See abstract
>
C.
Carina
Eklund
•
OC 14-10
•
Parallel testing for high-risk HPV and liquid based cytology in primary screening for cervical cancer
See abstract
>
J.
J.E
LEVI
•
OC 14-11
•
Implementation of HPV-test in primary screening has not decreased the attendance rate in the Norwegian cervical cancer screening programme
See abstract
>
B.
Birgit
Engesæter
•
OC 14-12
•
Randomized implementation of primary high risk human papillomavirus testing for cervical cancer screening in Norway
See abstract
>
M.
Mari
Nygård
•
OC 14-13
•
Quality indicators for primary HRHPV screening for cervical cancer
See abstract
>
W.
Wendy
Rodenburg
•
OC 14-14
•
Evaluation of colposcopy as a diagnostic triage for single visit screen and treat strategy in via based cervical cancer screening programs in India
See abstract
>
S.
Sharmila
Pimple
•
OC 14-15
•
Balancing benefits and harms in cervical cancer screening – a decision analysis for the Austrian health care context
See abstract
>
G.
Gaby
Sroczynski
•
OC 14-16
•
An analytical quality assessment programme for primary HRHPV screening in the Netherlands
See abstract
>
A.
Anton
Van Loon
•
OC 14-17
•
HPV self-sampling response rate in randomised study among Slovenian non-responders to the organised cervical cancer screening program
See abstract
>
U.
Urska
Ivanus
|